Cardiology Conditions Flashcards

1
Q

What is acute coronary syndrome

A

Refers to three states of myocardial ischaemia:

  • Unstable angina
  • ST elevation myocardial infarction (STEMI)
  • Non-ST elevation myocardial infarction (NSTEMI)

Myocardial infarction, AKA heart attack, refers to death of cardiac tissue (ie myocardial necrosis)

Defined as evidence of myocardial necrosis in a clinical setting consistent with acute myocardial ischaemia. Requires the detection of a cardiac biomarker, for diagnosis, (eg troponin) to show a rise and/or fall with at least one value above the upper limit for normal. There should also be at least one of:

  • Symptoms of MI
  • New or presumed new ECG changes
  • Development of pathological Q waves
  • Imaging evidence of infarction (loss of viable myocardium or new motion abnormality)
  • Angiography or autopsy evidence of thrombus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is myocardial infarction vs myocardial injury

A

Myocardial infarction: myocardial necrosis, seen as a rise in toponin, with evidence of acute myocardial ischaemia
Myocardial injury: myocardial necrosis, seen as a rise in troponin, without evidence of acute myocardial ischaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What causes acute coronary syndrome

A

Atherosclerosis is the predominant cause
It leads to narrowing of the coronary vessels which supply the heart
Narrowing secondary to atherosclerosis is known as coronary artery disease or ischaemic heart disease
CAD/IHD can lead to angina which refers to typical chest pain from myocardial ischaemia when there is an increase in the O2 supply/demand (eg on exertion), which quickly improves on rest
If an atheromatous plaque ruptures, it leads to thrombus formation and acute occlusion that causes ACS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the risk factors for ACS

A
Modifiable:
High cholesterol
Hypertension
Smoking
Diabetes
Obesity
Non-modifiable:
Age
Family history
Male
Premature menopause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does ACS present

A
Chest pain> 15 minutes (central crushing or pressing pain ± radiation to neck or arm
SOB
Sweating
Nausea and vomiting
Palpitations
Pale
Clammy
Tachycardia
Cardiac failure 

Severe complications:
Cardiac arrest
Life-threatening arrhythmia
Acute heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the differentials in ACS

A
Aortic dissection
PE
Peptic ulcer disease
Acute pericarditis
Oesophageal spasm
Costochondritis
Panic attack
Stable ischaemic heart disease
Myocardial 
Acute cholecystitis 
Boerhaave syndrome
Bruga syndrome
Acute stress cardiomyopathy
Pneumothorax
Pneumonia
Pericarditis
Myocarditis
GORD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is AF

A

Irregularly irregular heart rhythm

AF is where the contraction of the atria is uncoordinated, rapid and irregular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What causes AF

A

Normally the sinoatrial node produces organised electrical activity that coordinates the contraction of the atria of the heart
AF is due to disorganised electrical activity that overrides the normal, organised activity from the sinoatrial node.
The disorganised electrical activity of the atria also leads to irregualr conduction of electrical impulses to the ventricles

Most common causes of AF (mrs SMITH)
S-epsis
M-itral valve pathology (stenosis or regurgitation)
I-schaemic heart disease
T-hyrotoxicosis
H-ypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the risk factors for AF

A
Hypertension 
Underlying heart disease 
Drinking alcohol 
FHx
Sleep apnoea 
Chronic conditions (e.g., diabetes, hyperthyroidism, asthmas)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does AF present

A

Presenting symptoms can be:

  • Palpitations
  • SOB
  • Syncope (dizziness or fainting)
  • Symptoms of associated conditions (eg. stroke, sepsis, thyrotoxicosis)

Signs:
An ECG will show an abscence of p waves which reflects the lack of coordinate atrial electrical activity
Irregularly irregular ventricular contractions
Tachycardia
Heart failure due to poor filling of the ventricles during diastole
Risk of stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the differentials for irregularly irregular pulse

A
  • Atrial fibrillation
  • Ventricular ectopics

Can be differentiated using an ECG
ECG should be performed on everyone with an irregularly irregular pulse
Ventricular ectopics disappear when the heart rate gets over a certain threshold, therefore a regular heart rate during exercise suggests a diagnosis of ventricular ectopics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the differentials in suspected AF

A

Atrial flutter — characterised by a saw-tooth pattern of regular atrial activation on the electrocardiogram.
Atrial extrasystoles — common and may cause an irregular pulse.
Ventricular ectopic beats.
Sinus tachycardia — sinus rhythm with more than 100 beats per minute.
Supraventricular tachycardias, including atrial tachycardia, atrioventricular nodal re-entry tachycardia, and Wolff-Parkinson-White syndrome.
Multifocal atrial tachycardia — often seen in people with severe pulmonary disease.
Sinus rhythm with premature atrial or ventricular contractions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does AF present on ECG

A
  • Absent P waves
  • Narrow QRS complex tachycardia
  • Irregularly irregular ventricular rhythm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the CHA2DS2-VASc Score

A

Measure of thromboembolism risk in AF, and therefore whether to start on anticoagulants

C-congestive heart failure (1)
H-hypertension (1)
A-age >75 (2)
D-diabetes (1)
S-stroke/TIA/thromboembolism (2)
V-vascular disease (1)
A-age >65-74 (1)
S-sex category female (1)

Low risk – 0 (if a woman has no other risk factors gender is no longer significant)
Intermediate risk – 1
High risk > 2 – anticoagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the HAS-BLED score

A

Helps the identification of those at risk of significant bleeding on anticoagulation therapy.

H-hypertension
A-abnormal liver or renal function (1 point for each)
S-stroke
B-bleed (prior major/ predisposition)
L-labile INR
E-elderly >65
D-drugs or alcohol (1 point for each)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is AF treated

A

There are two principles to treating atrial fibrilation:

  • Rate or rhythm control
  • Anticoagulation to prevent stroke

Rate:
In AF the atrial contractions are not coordinated so the ventricles have to fill up by suction and gravity, which is less efficient.
The higher the heart rate, the less time available for the ventricles to fill with blood, reducing the cardiac output.
Aim is to decrease heart rate to below 100, to extend the time during diastole when the ventricles can fill with blood
Treatment options:
-Beta blocker is first line
-Calcium channel blocker (not in hear failure)
-Digoxin (only in sedentary people, needs monitoring and risk of toxicity)

Rhythm:
Aim is to return the patient to normal sinus rhythm
Can be achieved by a single cardioversion event that outs the patient back in to sinus rhythm or long term medical rhythm control that sustains a normal rhythm
Two options are:
-Pharmacological cardioversion (flecanide or amiodarone)
-Electrical cardioversion (involves sedation or a general anaesthetic and using a cardiac defibrillator to deliver controlled shocks in an attempt to restore sinus rhythm)
Long term medical rhythm control:
-Beta blockers (first line)
-Dronedarone (secondline where have had successful cardioversion)
-Amiodarone (useful in patients with heart failure or left ventricular dysfunction)

The uncontrolled and unorganised movement of the atria leads to blood stagnating in the left arium, particularly in the atrial appendage.
This can lead to a thrombus which can become an embolus and travel from the atria to the ventricle, to the aorta then up in the carotid arteries to the brain, it can then lodge in the cerebral arteries and cause on ischaemic stroke.
Options:
-Warfarin
-NOACs (Apixaban, dabigatran and rivaroxaban)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is angina

A

A narrowing of the coronary arteries reduces blood flow to the myocardium (heart muscle). During times of high demand such as exercise there is insufficient supply of blood to meet demand. This causes symptoms the symptoms of angina, typically constricting chest pain with or without radiation to jaw or arms.

Angina is “stable” when symptoms are always relieved by rest or glyceryl trinitrate (GTN).

It is “unstable” when the symptoms come on randomly whilst at rest, and this is considered as an Acute Coronary Syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How is angina investigated

A

CT Coronary Angiography is the Gold Standard diagnostic investigation. This involves injecting contrast and taking CT images timed with the heart beat to give a detailed view of the coronary arteries, highlighting any narrowing.

All patients should have to following as baseline investigations:

  • Physical Examination (heart sounds, signs of heart failure, BMI)
  • ECG
  • FBC (check for anaemia)
  • U&Es (prior to ACEi and other meds)
  • LFTs (prior to statins)
  • Lipid profile
  • Thyroid function tests (check for hypo / hyper thyroid)
  • HbA1C and fasting glucose (for diabetes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How is angina managed

A

There are four principles to management (RAMP):

R – Refer to cardiology (urgently if unstable)
A – Advise them about the diagnosis, management and when to call an ambulance
M – Medical treatment
P – Procedural or surgical interventions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How is angina medically managed

A

There are three aims to medical management:

  • Immediate Symptomatic Relief
  • Long Term Symptomatic Relief
  • Secondary prevention of cardiovascular disease

Immediate Symptomatic Relief:
Their GTN spray is used required. It causes vasodilation and helps relieves the symptoms.
Take GTN, then repeat after 5 minutes. If there is still pain 5 minutes after the repeat dose – call an ambulance.

Long Term Symptomatic Relief is with either (or used in combination if symptoms are not controlled on one):
-Beta blocker (e.g. bisoprolol 5mg once daily) or;
-Calcium channel blocker (e.g. amlodipine 5mg once daily)
Other options (not first line):
-Long acting nitrates (e.g. isosorbide mononitrate)
-Ivabradine
-Nicorandil
-Ranolazine

Secondary Prevention:

  • Aspirin (i.e. 75mg once daily)
  • Atorvastatin 80mg once daily
  • ACE inhibitor
  • Already on a beta-blocker for symptomatic relief.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How is angina surgically managed

A

Percutaneous Coronary Intervention (PCI) with coronary angioplasty (dilating the blood vessel with a balloon and/or inserting a stent) is offered to patients with “proximal or extensive disease” on CT coronary angiography. This involves putting a catheter into the patient’s brachial or femoral artery, feeding that up to the coronary arteries under xray guidance and injecting contrast so that the coronary arteries and any areas of stenosis are highlighted on the xray images. This can then be treated with balloon dilatation followed by insertion of a stent.

Coronary Artery Bypass Graft (CABG) surgery may be offered to patients with severe stenosis. This involves opening the chest along the sternum (causing a midline sternotomy scar), taking a graft vein from the patient’s leg (usually the great saphenous vein) and sewing it on to the affected coronary artery to bypass the stenosis. The recovery is slower and the complication rate is higher than PCI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the PCI scars

A

Brachial artery access

Femoral artery access

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the CABG scars

A

Midline sternotomy

Great saphenous vein harvesting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How is angina graded

A

The severity of angina can be graded according to the Canadian Cardiovascular Society.

  • Grade I: angina with strenuous activity (e.g. limitation on strenuous or prolonged ordinary activity).
  • Grade II: angina with moderate activity (e.g. slight limitation if normal activities performed rapidly).
  • Grade III: angina with mild exertion (e.g. difficulty climbing one flight of stairs at normal pace).
  • Grade IV: angina at rest (e.g. no exertion needed to trigger).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How common is angina

A

An estimated 2 million people in England have, or have experienced, angina.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Who is affected by angina

A

Smokers
Obese / DM / hypertensive patients
Those with a FHx of premature CAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is atherosclerosis

A

Atherosclerosis is an inflammatory process which predisposes individuals to angina and ACS.
Involves lipids, macrophages and smooth muscle.
Leads to the formation of an atheroma, which may contain plaque on its surface.
The presence of atherosclerosis within coronary vessels is termed coronary artery disease (CAD) or ischaemic heart disease (IHD) and it may be obstructive (i.e. >50% of the vessel lumen) or non-obstructive (<50% of the vessel lumen).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the risk factors for angina

A
Modifiable risk factors:
•	High cholesterol
•	Hypertension
•	Smoking
•	Diabetes
•	Obesity
Non-modifiable risk factors:
•	Age
•	Family history
•	Male sex
•	Premature menopause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the signs and symptoms of angina

A

The three classic features of angina include:

  • Constricting pain experienced in the chest +/- typical radiation to the arm/neck/jaw
  • Precipitated by physical exertion.
  • Relieved by rest or GTN within 5 minutes

Based on these classical features, angina can be differentiated into three types:
Typical: all three of the above features
Atypical: two of the above features
Non-anginal: ≤1 of the above features

Concerning chest pain
Chest pain lasts > 10 minutes
Chest pain not relived by two doses of GTN taken 5 minutes apart
Significant worsening/ deterioration in angina (e.g. increased frequency, severity or occurring at rest)
The above features may be suggestive of ACS and patients need immediate medical attention.

Cardiovascular examination

  • Heart sounds
  • Signs of heart failure

Dyspnoea

Palpitations
-Angina may be precipitated by tachyarrhythmias (e.g., AF). These increase the oxygen supply/demand mismatch and reduce filling time of the coronary vessels during diastole.

Syncope:
-May be suggestive of dangerous valvular or cardiac muscle disease causing angina, particularly if it occurs on exertion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the differentials in suspected angina

A
  • Myocarditis
  • Pericarditis
  • Pleuritis
  • PE
  • Aortic dissection
  • CHF
  • MI
  • GORD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are potential complications of angina

A
Cardiovascular complications of angina, caused by coronary artery disease, include: 
-Stroke.
-Myocardial infarction.
-Unstable angina. 
Sudden cardiac death.
Other complications include:
-Anxiety, and depression.
-Reduced quality of life.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is the prognosis of angina

A

The prognosis of stable angina is variable. Important indicators of long-term prognosis are the extent and severity of coronary artery disease, left ventricular function, exercise duration or effort tolerance, and comorbidities.

The prognosis depends on the time point at which the person is seen. For example, new-onset angina has a worse prognosis than established angina which has remained stable for some time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What is hypertension

A

Hypertension is the term used to describe high blood pressure, meaning a clinical bp measurement of 140/90 or an ambulatory/home reading of 135/85

Essential hypertension is also known as primary hypertension

Essentially means that the hypertension has developed on its own and does not have a secondary cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

How common is essential hypertension

A

Essential hypertension accounts for 95% of hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What causes hypertension

A

Essential hypertension develops on ots own and does not have a secondary cause

Secondary causes of hypertension can be remembered by mneumonic ROPE:
R-enal disease
O-besity
P-regnancy induced hypertension/ pre-eclampsia
E-ndocrine (most endocrine conditions can cause hypertension but primarily hyperaldosteronism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What are the risk factors for hypertension

A
Obesity
Aerobic exercise <3 times per week
Moderate to high alcohol intake
Metabolic syndrome
Diabetes
Black ancestry
Age >60 years old
Family history of hypertension or coronary artery disease
Sleep apnoea
Poor diet (high sodium, low fruit and veg)
Dyslipidaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

How does hypertension present

A
Signs and symptoms:
Often asymptomatic and detected through routine checks
Retinopathy
BP ≥140/90 mmHg
Headache
Visual changes
Dyspnoea
Chest pain
Sensory or motor deficit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What examination should be done on patients to screen for hypertension

A

Measure Blood pressure every 5 years to screen for hypertension but more often in those on the borderline for diagnosis and every year in pts with type 2 diabetes

Pts with clinic blood pressure readings between 140/90 and 180/120 should have a 24 hour ambulatory blood pressure or home readings to confirm diagnosis due to white coat syndrome potentially causing higher readings

39
Q

What are the differentials in hypertension

A
Essential hypertension
Renal artery stenosis
Chronic kidney disease
Obstructive uropathy
Obstructive sleep apnoea
Coarctation of aorta
Pre-eclampsia
Glomerulonephritis
Nephrotic syndrome
Polycystic kidney disease
Phaeochromocytoma
Hyperaldosteronism
Cushing's syndrome/disease
Hyperthyroidism
Hypothyroidism
Chronic alcohol excess
Medication
Illicit drug use 
White coat hypertension
40
Q

What would be discussed with hypertensive patients

A
Extra strain put on blood vessels
Sinister events may result:
Heart attacks
Heart disease
Heart failure
Strokes
Peripheral arterial disease
Abdominal aortic aneurysms
Kidney disease
Vascular dementia
Reducing blood pressure, can reduce the risk of these events occurring 
Important not to place blame on the patient as there is then a risk of alienation, and instead work cohesively to understand their struggles in controlling the modifiable risk factors.
41
Q

How is hypertension managed

A

Initial management:

  • Establish a diagnosis
  • Investigate for possible causes and end organ damage
  • Advise on lifestyle (healthy diet, smoking cessation, reducing alcohol, caffeine and salt intake, taking regular exercise

Medical management:

  • Offered to all with stage 2
  • All under 80y/o with stage 1 and a q-risk score of 10% or more, diabetes, renal disease, CV disease or end organ damage
Medications:
A- ACE inhibitor (rampipril)
B- Beta blocker (bisoprolol)
C- Calcium channel bllocker (amlodipine)
D- Thiazide like diuretic (imdopamide)
ARB- Angiotensin II respetor blocker (candesartan)

There are slightly different guidelines for younger patients and those aged over 55 or black:

Step 1: Aged less than 55 and non-black use A. Aged over 55 or black of African or African-Caribbean descent use C.
Step 2: A + C. Alternatively A + D or C + D. If black then use an ARB instead of A.
Step 3: A + C + D
Step 4: A + C + D + additional (see below)
For step 4, if the serum potassium is less than or equal to 4.5 mmol/l consider a potassium sparing diuretic such as spironolactone. If the serum potassium is more than 4.5 mmol/l consider an alpha blocker (e.g. doxazosin) or a beta blocker (e.g. atenolol).

Seek specialist advice if the blood pressure remains uncontrolled despite treatment at step 4.

42
Q

What are the potential complications of hypertension

A
Complications:
Ischaemic heart disease
Cerebrovascualr event (stroke or haemorrhage
Hypertensive retinopathy
Hypertensive nephropathy
Heart failure
43
Q

How is hypertension staged

A

Stage 1: >140/90 (clinical) >135/85 (home)

Stage 2: >160/100 (clinical) >150/95 (home)

Stage 3: >180/120 (clinical)

44
Q

What is a DVT

A

The development of a blod clot in a major deep vein in the leg, thigh, pelvis, or abdomen, which may result in impaired venous blood flow and consequent leg swelling and pain

Venous thrombosis may also occur in the upper extremities or in more unusual sites, such as the portal, mesenteric, ovarian and retinal veins, as well as the veins and venous sinuses of the brain.

Superficial vein thrombosis, thrombosis affecting veins superficial to the musculature, also commonly occurs

Venous thromboembolism is the broad term that inclused DVT and pulmonary embolism

45
Q

How common are DVTs

A

Yearly incidence of VTE is ~ 1 in every 1000 adults and ~ 2/3 of all cases are DVT
Estimated that 300,000 deaths per year are due to VTE

46
Q

What causes DVTs

A

Usually occurs secondary to stagnation of blood and hyper-coagulable states

47
Q

What are the risk factors for DVTs

A
Immobility
Recent surgery
Long haul flights
Pregnancy
Hormone therapy with oestrogen (combine oral contraceptive pill and hormone replacement therapy)
Malignancy
Polycythaemia
Systemic lupus erythematous
Thrombophilia (conditions that predispose patients to develop blood clots):
- Antiphospholipid syndrome
- Antithrombin deficiency
- Protein C or S deficiency
- Factor V leiden
- Hyperhomocysteinaemia
- Prothombin gene variant
- Activated protein C resistence
48
Q

How does a DVT present

A
Almost always unilateral
Bilateral DVT is rare and bilateral symptoms are more likely due to an alternative diagnosis such as chronic venous insufficiency or heart failure
DVTs can present with:
-Calf or leg swelling
-Dilated superficial veins
-Tenderness to the calf (particularly over the site of the deep veins)
-Oedema
-Colour changes to the leg
49
Q

What signs may a DVT patient show on examination

A

To examine for leg swelling measure the circumference of the calf 10cm below the tibial tuberosity
More than 3cm difference between calves is significant
Always examin with the suspicion of a potential pulmonary embolism as well

Wells score:
Predicts the risk of a pt presenting with symptoms having a DVT or PE
Takes in to account risk factors such as recent surgery and clincial findings such as unilateral calf swelling 3cm greater than the other leg

50
Q

What are the differentials in suspected angina

A

Cellulitis
Calf muscle tear/ Achilles’ tendon tear
Calf muscle haematoma
Large or ruptures popliteal cyst (Baker’s cyst)
Pelvic/ thigh mass/ tumour compressing venous outflow from the leg

51
Q

How would a suspected DVT be investigated

A

D-dimer is a sensitive (95%) but not specific blood test for VTE
This makes it useful for exluding VTE where there is a low suspicion
Almost always raised if there is a DVT, however other conditions can also cause a raised d-dimer:
-Pneumonia
-Malignancy
-Heart failure
-Surgery
-Pregnancy

Ultrasound doppler of the leg is required to diagnose DVT
NICE recommend repeating negative ultrasound scans after 6-8 days if there is a positive D-dimer and the Wells score suggest a DVT is likely

PE can be diagnosed with a CT pulmonary angiogram or VQ scan

Investigating unprovoked DVT:

  • Recommended to investigate for possible cancer
    • History and examination
    • Chest X-ray
    • Bloods (FBC, calcium, LFTs)
    • Urine dipstick
    • CT abdomen and pelvis in patients over 40
    • Mammogram in women over 40
  • Also test for antiphospholipid syndrome by checking for antiphospholipid antibodies
  • Those with an unprovoked VTE with a family history of VTE, recommended to test for hereditary thrombophilias:
    • Factor V Leiden
    • Prothrombin G20210A
    • Protein C
    • Protein S
    • Antithrombin
52
Q

How is a DVT managed

A

Initial management

  • Treatment dose low molecular weight heparin
  • Start immediately before confirming the diagnosis in pts where DVT or PE is suspected and there is a delay in getting the scan
  • Examples are enoxaparin and dalteparin

Switching to long term anticogulation:
-Warfarin, NOAC, DOAC or LMWH
-Target INR for warfarin is 2-3. When switching to warfarin, continue LMWH for 5 days or the INR is 203 for 24 hours on warfarin (whichever is longer)
-NOAC or DOAC are oral anticoagulants that are not warfarin. They are an alternative option for anticoagulation that does not require monitoring. Originally they were called novel oral anticoagulants but this has been changed to non-vitamin K oral anticoagulants because they are no longer novel
This is changing to DOACs, standing for direct acting oral anticoagulants
Main three options are apixaban, dabigatran and rivaroxaban
-LMWH long term is first-line treatment in pregnancy or cancer

Continue anticoagulation for:

  • 3 months if there is an obvious reversible cause (then review)
  • Beyond 3 months if the cuase is unclear, there is recurrent VTE or there is an irreversible underlying cause, such as thrombophilia, often 6 months in practice
  • 6 months in active cancer (then review)

Inferior Vena Cava Filter:

  • Devices inserted into the IVC
  • Designed to filter the blood and catch any blood clots travelling from the venous system towards the heart and lungs
  • Act like a sieve, allowing blood to flow through whilst stopping larger blood clots
  • They are used in unusual cases of patients with recurrent PEs or those that are unsuitable for anticoagulation to prevent emboli traveling to the lungs
53
Q

What is Budd-Chiari Syndrome

A
A blood clot develops in the hepatic vein, blocking the outflow of blood 
Associated with hyper-coagulable states
Causes an acute hepatitis
Presents with a classic triad of:
-Abdominal pain
-Hepatomegaly
-Ascites
54
Q

What is left ventricular failure

A

Occurs when the left ventricle is unable to adequately move blood through the left side of the heart and out into the body.
This causes a backlog of blood that increases the amount of blood stuck in the left atrium, pulmonary veins and lungs.
As the vessels in these areas are engorged with blood due to the increased volume and pressure they leak fluid and are unable to reabsorb fluid from the surrounding tissues.
This causes pulmonary oedema, which is where the lung tissues and alveoli become full of interstitial fluid.
This interferes with the normal gas exchange in the lungs, causing shortness of breath, oxygen desaturation and the other signs and symptoms.

55
Q

What is stroke volume

A

The amount of blood pumped out of the heart from each contraction

56
Q

What is cardiac output

A

The amount of blood pumped out of the heart in one minute

Equivalent to Heart Rate x Stroke Volume

57
Q

What is preload

A

Stretching of cardiomyocytes at the end of diastole

58
Q

What is afterload

A

Pressure or load against which the ventricles must contract

59
Q

What is inotropy

A

Refers to myocardial contractility (ie. the force of muscular contraction)

60
Q

How common is LVF

A

Most common type of heart failure

61
Q

Who does LVF affect

A

More common in elderly patient

62
Q

What is the aetiology of LVF

A

The most common aetiologies of left heart failure are coronary artery disease and hypertension. The latter can cause left heart failure through left ventricular hypertrophy and also serves as a risk factor for coronary artery disease.

Iatrogenic (e.g., aggressive IV fluids in frail elderly patient with impaired left ventricular function) which causes a low-output HF due to excessive preload. This can cause ventricular dilation and exacerbates pump failure.
Sepsis
Myocardial infarction
Arrhythmias
Mitral regurgitation (causes excessive preload)
Aortic stenosis / HTN (causes excessive afterload leading to myocardial hypertrophy which then leads to stiff walls & diastolic dysfunction)

63
Q

What are the risk factors for LVF

A
Old age
Obesity
Male sex
Diabetes
Sedentary lifestyle
64
Q

How does LVF present

A
Dyspnoea 
Looking and feeling unwell 
Poor exercise tolerance 
Fatigue 
Orthopnoea 
Paroxysmal nocturnal dyspnoea 
Nocturnal cough (+ frothy white/pink sputum) 
Displaced apex (if LV is dilated) 

Some patients with advanced disease might experience weight loss, referred to as “cardiac cachexia”.

65
Q

What signs will be on examination in those with LVF

A

O/E
Increased respiratory rate
Reduced oxygen saturation
Tachycardia
3rd heart sound (S3 gallop – indicative of elevated ventricular end-diastolic pressure)
Bilateral basal crackles on auscultation
Rales on lung auscultation suggestive of pleural effusion
Hypotension in severe cases (cardiogenic shock)
Increased abdominal girth due ascites.
Reduced kidney perfusion
o Pre-renal azotaemia / RAAS activation
Irritability, restlessness, stupor and coma (Advanced cardiac failure can lead to cerebral hypoxia causing these signs/Sx)

Signs related to underlying cause:
Chest pain in ACS
Fever in sepsis
Palpitations in arrhythmias

If they also have right sided heart failure as a result you could find:
Raised Jugular Venous Pressure (JVP)
Peripheral oedema (ankles, legs, sacrum).

66
Q

What are the differentials in LVF

A

Dyspnoea – primary pulmonary HTN, COPD, interstitial lung disease, anaemia
Oedema – venous insufficiency, cirrhosis, nephrotic syndrome, lymphoedema, DVT

67
Q

What investigations should be performed in LVF

A

ECG
May indicate cause – look for ischaemia, arrhythmias, MI and ventricular hypertrophy.

Chest Xray
-Cardiomegaly on a CXR is defined as a cardiothoracic ratio of more than 0.5. This is when the diameter of the widest part of the heart (the wides part of the cardiac silhouette) is more than half the diameter of the widest part of the lung fields.
-Upper lobe venous diversion. Usually when standing erect the lower lobe veins contain more blood and the upper lobe veins remain relatively small. In LVF there is such a back-pressure that the upper lobe veins also fill with blood and become engorged (referred to as upper lobe diversion). This is visible as increased prominence and diameter of the upper lobe vessels on a chest xray.
-Fluid leaking from oedematous lung tissue causes additional xray findings of:
o Bilateral pleural effusions
o Fluid in interlobar fissures
o Fluid in the septal lines (Kerley lines)

Echocardiography
-Useful in assessing the function of the left ventricle and any structural abnormalities in the heart.
-The main measure of the left ventricular function is the ejection fraction.
o This is the percentage of the blood in the left ventricle is squeezed out with each ventricular contraction.
o An ejection fraction above 50% is considered normal.
-TTE can differentiate HF into three groups:
o Heart failure with reduced ejection fraction (HFrEF): LVEF <40%
 Causes: ID, MI, cardiomyopathy
 Systolic failure
o Heart failure with minimally reduced ejection fraction (HFmrEF): LVEF 40-49%
o Heart failure with preserved ejection fraction (HFpEF): LVEF ≥50%
 Ventricular hypertrophy, constrictive pericarditis, tamponade, restrictive cardiomyopathy, obesity.
 Diastolic failure

Bloods
•FBC’s – for signs of infection
•U&Es – for kidney function – low sodium indicates advanced disease.
•LFTs – detect liver injury dur to volume overload
•BNP
o B-type Natriuretic Peptide is a hormone release from the heart ventricles when the myocardium is stretched beyond the normal range.
o High result indicated the heart is overloaded beyond its normal capacity to pump effectively.
o Action of BNP is to relax the smooth muscle in blood vessels.
o BNP also acts on the kidneys as a diuretic.
•Troponin – if suspecting MI
•ABG

Coronary angiography
•Indicated in patients with anginal symptoms.

68
Q

How is LVF treated

A
Pour Sod 
P-pour away (stop) their IV fluids 
S-sit up 
O-oxygen 
D-diuretics (furosemide 40mg stat) 
- SE: ↓K+ - if refractory oedema consider adding metolazone (5-20mg/24hrs PO) 

Education
-Patients should receive education on the importance of lifestyle modification
o Avoidance of alcohol, nicotine and recreational drugs
o Reasonable salt consumption

Treating the underlying cause
- Some heart failure conditions may be reversible when the precipitating factors are addressed, like cardiomyopathies induced by alcohol, tachycardia or ischemia. Tight control of blood pressure will also help prevent further deterioration.

Beside treatment
- Loop diuretics for volume overload

Medication
Pharmacological treatments differ between HFrEF and HFpEF

•HFrEF
o ACEi (e.g., Ramipril) OR ARBs (e.g., Candesartan)
 If cough is a problem ARB may be substituted.
o + Beta blocker (e.g., bisoprolol, carvedilol, metoprolol)
 ↓mortality in patients

•HFpEF
o Control of BP
o Revascularisation (if ischameic cardiomyopathy)
o Management of arrhythmias
o Minneralcorticoid receptor antagonist may be beneficial in these patients. (e.g., Spironolactone 25mg/24hrs PO)

Digoxin (125mcg/24hrs PO) can help with symptoms
Vasodilators - Hydralazine (SE: drug-induced lupus) and isosorbide dinitrate should be used if intolerant to ACE-I and ARBs as it reduced mortality. It also reduced mortality when added to standard therapy (including ACE-i) in black patients with HF.

Other options to consider in severe acute pulmonary oedema or cardiogenic shock (not routinely used) include:
•Intravenous opiates (opiates such as morphine act as vasodilators but are not routinely recommended).
•Non-Invasive Ventilation (NIV). Continuous Positive Airway Pressure (CPAP) involves using a tight fitting mask to forcefully blow air into their lungs. This helps to open the airways and alveoli to improve gas exchange. If NIV does not work they may need full intubation and ventilation.
•“Inotropes”, for example an infusion of noradrenalin. Inotropes strengthen the force of heart contractions and improve heart failure, however they need close titration and monitoring, so by this point you would need to send the patient to the local coronary care unit / high dependency unit / intensive care unit.

69
Q

What are the potential complications of LVF

A

Right Ventricular Failure
-When LVF and RVF occur together it is known as congestive heart failure.

Cardiogenic shock 
CVA 
Acute coronary syndrome 
PE 
Arrhythmias 
Anasarca (extreme generalised oedema)
70
Q

What is the prognosis of LVF

A

The mortality rate in heart failure in 2008 was 18.2 per 100,000 for males and 15.8 per 100,000 for females.

Worse outcome in heart failure: male gender, advancing age, low ejection fraction, high NYHA functional class, low haematocrit, and sodium levels, high brain natriuretic peptide, low peak exercise oxygen uptake, wide QRS, renal failure, low blood pressure, elevated heart rate, and volume overload refractory to medical treatment.

71
Q

What are the classifications of LVF

A

Heart failure with preserved ejection fraction (HFpEF) with ejection fraction over 50 percent.

Heart failure with reduced ejection fraction (HFrEF) with ejection fraction less than 40 percent.

Heart failure with mid-range ejection fraction, with ejection fraction between 41 and 49 percent

72
Q

What is heart failure

A

Is a condition in which the heart is unable to generate a cardiac output sufficient to meet the demands of the body without increasing diastolic pressure.
It can result from any cardiac disease that compromises ventricular systolic or diastolic function or both.

73
Q

What is congestive heart failure

A

Is the term used to described patients with breathlessness and abnormal sodium and water retention resulting in oedema.
It is a result of a failure of both the right and left side of the heart.

74
Q

What is systolic heart failure

A

Reduced left ventricular ejection fraction (LVEF) - the heart is pumping out a reduced proportion of the blood that fills its ventricles during diastole.
Results in ventricular dilatation and characteristic eccentric remodelling

75
Q

What is diastolic heart failure

A

Impaired ventricular relaxation or filling.
Contraction is unaffected and as such the LVEF is preserved.
Diastolic heart failure may be called ‘heart failure with preserved LVEF’.
Ventricular hypertrophy tends to develop and characteristic concentric remodelling may occur.

76
Q

What is acute heart failure

A

Rapid onset of worsening symptoms and/or signs of heart failure
Life-threatening condition that requires urgent evaluation and treatment
May occur acutely (e.g. cardiogenic shock) or as a consequence of acute decompensation of chronic heart failure
Most common causes of acute heart failure include acute myocardial dysfunction (ischaemic, inflammatory), acute valvular disease, pericardial tamponade.

77
Q

What is chronic heart failure

A

Progressive cardiac dysfunction due to structural and/or functional cardiac abnormalities
Results in reduced cardiac output and/or elevated intracardiac pressures at rest or on stress
Precipitated by conditions that affect the muscles (e.g. cardiomyopathy), vessels (e.g. ischaemic heart disease), valves (e.g. aortic stenosis), or conduction (e.g. atrial fibrillation)
Patients develop chronic, progressive symptoms but may present with acute decompensation.

78
Q

How common is congestive heart failure

A

The prevalence of CHF in the western world has been estimated at 1% to 2%, and the incidence is thought to approach 5 to 10 per 1000 people per year.

79
Q

Who is affected by congestive heart failure

A

Prevalence increases with age

80
Q

What are the common causes of chronic heart failure

A
Coronary artery disease
Hypertension - results in excess preload of atrium. Permanent dilation of ventricles and loss of elastic tissue
Valvular disease (commonly aortic stenosis) 
Myocarditis. 
Ischaemic heart disease 
Arrhythmias (commonly AF) 
Cardiomyopathy (dilated/ hypertrophic) 
Congenital heart disease 
Beta blockers
81
Q

What are the risk factors for congestive heart failure

A
MI 
DM
Dyslipidaemia 
Old age 
Male 
HTN 
Cocaine abuse 
FHx
High alcohol intake
82
Q

How does congestive heart failure present

A
Dyspnoea 
Orthopnoea 
Paroxysmal nocturnal dyspnoea (PND) 
Wheeze 
Fatigue 
Weight loss 
Fluid retention - Ankle swelling / bloated feeling 
Night cough 
Syncope / light-headedness
83
Q

What signs will be on examination of congestive heart failure

A
S3 gallop 
Cardiomegaly – displaced apex 
Hepatojugular reflux 
Raised JVP / HTN 
Neck vein distention 
Hepatomegaly (due to engorement)
Ascites
Bibasal crackles on auscultation of lung bases 
Peripheral oedema / pitting oedema 
Tachycardia (HR >120BPM) 
Cyanosis 
Narrow pulse pressure
84
Q

What are the differential diagnoses for congestive heart failure

A
COPD/pulmonary fibrosis 
Pneumonia 
PE
Cirrhosis 
Venous stasis 
Post-partum cardiomyopathy
85
Q

What are the investigations for congestive heart failure

A

BNP blood test (specifically “N-terminal pro-B-type natriuretic peptide” – NT‑proBNP)
•Protein released by cardiomyocytes in response to excessive stretching.
•Used to assess likelihood of heart failure.
•Other conditions that may raise BNP:
- Diabetes
- Sepsis
- Old age
- Hypoxaemia (PE, COPD)
- Kidney disease
- Liver cirrhosis.

Transthoracic Echocardiogram (TTE)
•Main investigation for the confirmation of heart failure.
•Allows for the accurate determination of biventricular systolic and diastolic function.
•Systolic heart failure: echo usually demonstrates a dilated left and/or right ventricle with low ejection fraction.
•Pure diastolic heart failure: left ventricular ejection fraction (LVEF) is normal but there is evidence of left ventricular hypertrophy (LVH) and of abnormal diastolic filling patterns on Doppler evaluation.

ECG
•Evidence of underlying coronary artery disease, left ventricular hypertrophy, or atrial enlargement; may be conduction abnormalities and abnormal QRS duration

CXR
•Cardiomegaly (Cardiothoracic ratio > 50% on PA film)
•Pleural effusion

Cardiac MRI
•May be used when transthoracic echo is non-diagnostic
•May be used to determine the aetiology of heart failure (e.g. ischaemic versus non-ischaemic in dilated cardiomyopathy)

Bloods
•FBC – exclude anaemia, infective cause.
•U&Es – exclude renal failure as a cause of oedema
•LFT – exclude liver failure as a cause of oedema.
•TFTs – exclude thyroid disease
•Cholesterol and HbA1c – cardiovascular risk stratification
•BNP

Special tests:
•Coronary angiogram: used for diagnostic and therapeutic purposes to diagnose/treat coronary artery disease
•Right heart catheterisation: reserved for the investigation of right-sided heart failure
•24 hr ECG: if an arrhythmia is suspected
•Lung function tests: to exclude alternative pathology impacting on symptoms (e.g. breathlessness)

Framingham Criteria

86
Q

How is congestive heart failure managed

A

Management
•Refer to specialist (NT-proBNP > 2,000 ng/litre warrants urgent referral)
•Careful discussion and explanation of the condition
•Medical management (see below)
•Surgical treatment in severe aortic stenosis or mitral regurgitation
•Heart failure specialist nurse input for advice and support

Additional management:
•Yearly flu and pneumococcal vaccine.
•Stop smoking & drinking alcohol.
•Optimise treatment of co-morbidities.
•Exercise at tolerated level. 
•Reduce sodium intake + fluid restriction + weight monitoring.

First Line Medical Treatment (ABAL)
A-CE inhibitor (e.g. ramipril titrated as tolerated up to 10mg once daily)
B-eta Blocker (e.g. bisoprolol titrated as tolerated up to 10mg once daily)
A-ldosterone antagonist when symptoms not controlled with A and B (spironolactone or eplerenone)
L-oop diuretics improves symptoms (e.g. furosemide 40mg once daily)

Extra detail on medical treatment
•An Angiotensin Receptor Blocker (ARB) can be used instead of an ACE inhibitor if ACE inhibitors are not tolerated (for example candesartan titrated up to 32mg once daily).
•Avoid ACE inhibitors in patients with valvular heart disease until indicated by a specialist.
•Aldosterone antagonists are used when there is a reduced ejection fraction and symptoms are not controlled with an ACEi and beta blocker.
•Patients should have their U&Es monitored closely whilst on diuretics, ACE inhibitors and aldosterone antagonists as all three medications can cause electrolyte disturbances.

87
Q

What are potential complications of congestive heart failure

A
  • Pleural effusion
  • Chronic renal insufficiency
  • Anaemia
  • Acute decompensation of chronic heart failure
  • Acute renal failure
  • Sudden cardiac death
88
Q

What is the prognosis of congestive heart failure

A
  • Despite standard medical therapy the survival for patients with end-stage heart failure is poor.
  • Only 65% of patients in NYHA class 4 are alive at a mean follow-up of 17 months.
  • ~25-50% of patients die within 5yrs of diagnosis.
89
Q

What are chest pain differentials

A

Cardiac:

  • Angina
  • Acute coronary syndrome
  • Aortic dissection
  • Pericarditis

Respiratory:

  • PE
  • Pneumothorax
  • Pneumonia

Gastrointestinal:

  • Oesophagitis
  • Oesophageal spasm
  • Peptic ulcer disease

Other

  • Costochondritis
  • Rib fracture
  • Herpes zoster
  • Depression/ anxiety
90
Q

How is suspected acute coronary syndrome investigated

A

Initial assessment
•ABCDE (if acutely unwell) followed by brief history & examination.
•ECG: urgent ECG to look for ST elevation or left bundle branch block (LBBB). If absent, look for other features of ischaemia (e.g. ST depression, T wave inversion)
•Cardiac enzymes: troponin is the only recognises biomarker for the diagnosis of myocardial necrosis.

Other investigations :
Perform all the investigations you would normally arrange for stable angina:
•Physical Examination (heart sounds, signs of heart failure, BMI)
•ECG
•FBC (check for anaemia)
•U&Es (prior to ACEi and other meds)
•LFTs (prior to statins)
•Lipid profile
•Thyroid function tests (check for hypo / hyper thyroid)
•HbA1C and fasting glucose (for diabetes)

Plus:
•Chest xray to investigate for other causes of chest pain and pulmonary oedema
•Echocardiogram after the event to assess the functional damage
•CT coronary angiogram to assess for coronary artery disease

Making a diagnosis
•When a patient presents with possible ACS symptoms (i.e. chest pain) perform an ECG.
•If there is ST elevation or new LBBB the diagnosis is STEMI.
•If there is no ST elevation then perform troponin blood tests.
-If there are raised troponin levels and/or other ECG changes (ST depression or T wave inversion or pathological Q waves) the diagnosis is NSTEMI.
-If troponin levels are normal and the ECG does not show pathological changes the diagnosis is either unstable angina or another cause such as musculoskeletal chest pain.

91
Q

How is ACS treated

A
ACS immediate management = MONA  
(IV) Morphine (+ antiemetic)
Oxygen
Nitrates (e.g., GTN)
Aspirin (300mg)

Acute STEMI Treatment (always check local protocol)
Patients with STEMI presenting within 12 hours of onset should be discussed urgently with local cardiac centre for either:
•Primary PCI (if available within 2 hours of presentation)
•Thrombolysis (if PCI not available within 2 hours)
– Examples: Streptokinase, Alteplase, Tenecteplase
– Significant bleeding risk can make this dangerous
•The local cardiac centre will advise about further management (such as further loading with aspirin and ticagrelor).

Acute NSTEMI treatment: BATMAN
B – Beta blockers unless contraindicated
A – Aspirin 300mg stat dose
T – Ticagrelor 180mg stat dose (clopidogrel 300mg is an alternative)
M – Morphine titrated to control pain
A – Anticoagulant: Low Molecular Weight Heparin (LMWH) at treatment dose (e.g. enoxaparin 1mg/kg twice daily for 2-8 days)
N – Nitrates (e.g. GTN) to relieve coronary artery spasm
Give oxygen only if their oxygen saturations are dropping (i.e. <95%).

GRACE Score to assess for PCI in NSTEMI:
This scoring system gives a 6-month risk of death or repeat MI after having an NSTEMI:
•<5% Low Risk
•5-10% Medium Risk
•>10% High Risk
If they are medium or high risk they are considered for early PCI (within 4 days of admission) to treat underlying coronary artery disease.

Secondary Prevention Lifestyle:
•Stop smoking
•Reduce alcohol consumption
•Mediterranean diet
•Cardiac rehabilitation (a specific exercise regime for patients post MI)
•Opimise treatment of other medical conditions (e.g. diabetes and hypertension)

92
Q

What are the complications of MI

A

DREAD

D-death
R-rupture
E-edema (heart failure)
A-arrhythmia
D-dressler's syndrome
93
Q

What is Dressler’s syndrome

A

This is also called post-myocardial infarction syndrome. It usually occurs around 2-3 weeks after an MI. It is caused by a localised immune response and causes pericarditis (inflammation of the pericardium around the heart). It is less common as the management of ACS becomes more advanced.

It presents with pleuritic chest pain, low grade fever and a pericardial rub on auscultation. It can cause a pericardial effusion and rarely a pericardial tamponade (where the fluid constricts the heart and prevents function).

A diagnosis can be made with an ECG (global ST elevation and T wave inversion), echocardiogram (pericardial effusion) and raised inflammatory markers (CRP and ESR).

Management is with NSAIDs (aspirin / ibuprofen) and in more severe cases steroids (prednisolone). They may need pericardiocentesis to remove fluid from around the heart.

94
Q

What is the prognosis of ACS

A

The rate of sudden death in patients who have had a myocardial infarction is 4 to 6 times the rate in the general population.
Statins and revascularisation, has decreased morbidity and mortality by reducing the likelihood of cardiogenic shock, recurrent myocardial infarction, and death. However, these benefits are offset by the mortality associated with trends of older age in patients who present with acute coronary syndrome.